J. Hunziker

发表

Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?

J. Weiler, J. Hall, J. Hunziker, 2006, Gene Therapy.

Whole-body scanning PCR; a highly sensitive method to study the biodistribution of mRNAs, noncoding RNAs and therapeutic oligonucleotides

I. Beuvink, P. Neuner, D. Morrissey, 2013, Nucleic acids research.

Design of an N7-Glycosylated Purine Nucleoside for Recognition of GC Base Pairs by Triple Helix Formation

P. Dervan, J. Hunziker, E. Priestley, 1995 .

Site-specific conjugation of drug-like fragments to an antimiR scaffold as a strategy to target miRNAs inside RISC.

Jonathan Hall, J. Hall, J. Hunziker, 2016, Chemical communications.

Synthesis of 5-(2-amino-2-deoxy-beta-D-glucopyranosyloxymethyl)-2'- deoxyuridine and its incorporation into oligothymidylates.

J. Hunziker, 1999, Bioorganic & medicinal chemistry letters.

Structural basis of siRNA recognition by TRBP double‐stranded RNA binding domains

J. Weiler, B. Schuler, G. Jeschke, 2018, The EMBO journal.

X‐ray Structures and Feasibility Assessment of CLK2 Inhibitors for Phelan–McDermid Syndrome

N. Stiefl, A. Elhajouji, Ivan Galimberti, 2018, ChemMedChem.

2′-Deoxy-2′(S)-ethynyl Oligonucleotides: Synthesis and Pairing Properties

J. Hunziker, R. Buff, 1999 .